Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue SUPPL. A, 1996, Pages 105-114

  Gehanno, P ^a   Berche, P ^b   Danon, ^c   Darmon, ^c   Car, ^c   Amsellem, ^c   Timsit, ^c   Nemi, ^c   Tlili, ^c   Trotin, ^c   Cambriel, ^c   Levy, ^c   Meaux, ^c   Lafosse, ^c   Blassin, ^c   Hamman, ^c   Lefranc, ^c   Marsac, ^c   Reboul, ^c   Donnadieu, ^c   Lefebvre, ^c   Aronio De Ron, ^c   Deloix Vericel, ^c   Duboux, ^c   Flieder, ^c   Rousselet, ^c   Samson, ^c   Vericel, ^c   Tsigardis, ^c   Popot, ^c   Jacquin, ^c   Huart, ^c   Ebbo, ^c   Dufour, ^c   Cornubert, ^c   Baculard, ^c   Meunier, ^c   Lopez Moya, ^c   Vigneron, ^c   Bonnard, ^c   Isasa, ^c   Bourrel, ^c   Agustin, ^c   Assous, ^c   Banal, ^c   Barrier, ^c   Betsch, ^c   Bringart, ^c   Cassat, ^c   Chattey, ^c   Chevet, ^c   Gavilan, ^c   Grison, ^c   Guedon, ^c   Guerin, ^c   Janssen, ^c   Kraimps, ^c   Lelievre ^c   Miller, ^c   Pichelin, ^c   Alvarez Vincent, ^c   Sabatier, ^c   more..

^a BICHAT HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME AXETIL; SPARFLOXACIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHOTOTOXICITY; RANDOMIZED CONTROLLED TRIAL; RASH; SINUSITIS; STREPTOCOCCUS PNEUMONIAE;

ACUTE DISEASE; ADULT; ANTI-INFECTIVE AGENTS; CEFUROXIME; CEPHALOSPORINS; DOUBLE-BLIND METHOD; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; PRODRUGS; QUINOLONES; SINUSITIS;

EID: 9344256661     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.1.105     Document Type: Article

References (21)

1. Barry, A. L. & Fuchs, P. C. (1991). In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin. Antimicrobial Agents and Chemotherapy 35, 955-60.
2. Camacho, A. E., Cobo, R., Otte, J., Spector, S. L., Lerner, C. J., Garrison, N. A. et al. (1992). Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis. American Journal of Medicine, 93, 271-6.
3. Canton, R., Peman, J., Jimenez, M. T., Ramon, M. S. & Gobernado, M. (1992). In vitro activity of sparfloxacin compared with those of five other quinolones. Antimicrobial Agents and Chemotherapy 36, 558-65.
4. Chin, N. X., Gu, J. W., Yu, K. W., Zhang, Y. X. & Neu, H. C. (1991). In vitro activity of sparfloxacin. Antimicrobials Agents and Chemotherapy 35, 567-71.
5. Cooper, M. A., Andrews, J. M., Ashby, J. P., Mattews, R. S. & Wise, R. (1990). In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent. Journal of Antimicrobial Chemotherapy 26, 667-76.
6. Dabernat, H. (1991). Centre National de Référence pour Haemophilus influenzae. Rapport d'activités, année, 1990. Bulletin Epidémiologique Hebdomadaire 33, 140-1.
7. Gehanno, P., Depondt, J., Barry, B., Simonet, M. & Dewever, H. (1990). Comparison of cefpodoxime proxetil with cefaclor in the treatment of sinusitis. Journal of Antimicrobial Chemotherapy 26, Suppl. E, 87-91.
8. Gehanno, P., Boucot, I., Chiche, D. & Berche, P. (1991). Treatment of community acquired acute sinusitis: cefuroxime axetil vs cefixime. Médecine et Maladies Infectieuses, Suppl. 21, 61-5.
9. Geslin, P., Fremaux, A. & Sissia, G. (1992). Evolution de la résistance des pneumocoques responsables des infections des voies respiratoires en France. Médecine et Maladies Infectieuses 22, 74-86.
10. Honeybourne, D., Greaves, I., Baldwin, D. R., Andrews, J. H., Harris, M. & Wize, R. (1994). The concentration of sparfloxacin in lung tissues after single and multiple oral doses. International Journal of Antimicrobial Agents 4, 151-5.
11. Körner, R. J., Reeves, D. S. & MacGowan, A. P. (1994). Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections. British Medical Journal 308, 191-2.
12. Jousmies-Somer, H. R., Savolainen, S. & Ylikoski, J. (1988). Bacteriological findings of acute maxillary sinusitis in young adults. Journal of Clinical Microbiology 26, 1919-25.
13. Lowenstein, S. R. & Parrino, T. A. (1987). Management of the common cold. Advances in Internal Medicine 32, 207-33.
14. Massias, L., Cohen, B., Cudennec, Y. Farinotti, R., Buffe, P. & Gehanno, P. (1993). Distribution of sparfloxacin into the tissue structures of the ENT spheres. In Proceedings of the Eighteenth International Congress of Chemotherapy, Venue, 1993. Abstract 533.
15. Rolston, K. V. I., Nguyen, H., Messer, M., LeBlanc, B., Ho, D. H. & Bodey, G. P. (1990). In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients. Antimicrobial Agents and Chemotherapy 34, 2263-6.
16. Patron, C., Baguero, F., Monteagudo, J. L. & Vicente, M. F. (1991). Post antibiotic effect of sparfloxacin. European Journal of Clinical and Microbiology and Infectious Disease Special Issue, 537-40.
17. Scandinavian Study Group (1993). Loracarbef versus doxycycline in the treatment of acute bacterial maxillary sinusitis. Journal of Antimicrobial Chemotherapy 31, 949-61.
18. Shimada, J., Nogita, T. & Ishibashi, Y. (1993). Clinical pharmacokinetics of sparfloxacin. Clinical Pharmacokinetics 25, 358-69.
19. Visser, M., Rozenberg-Arska, M., Breumer, H., Hoepelman, I. M. & Verhoef, J. (1991). Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone. Antimicrobial Agents and Chemotherapy 35, 858-68.
20. Wise, R. & Honeybourne, D. (1996). A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses. Journal of Antimicrobial Chemotherapy 37, Suppl. A, 57-63.
21. Ylikoski, J., Savolainen, S. & Jousimies-Somer, H. (1989). The bacteriology of acute maxillary sinusitis. Journal of Oto-Rhino-Laryngology and its Related Specialities 51, 175-81.